Scrambles

While I was looking if it is a good time to buy Boeing, the airline maker,  I found this interesting article in one of the fora.  I am copy-pasting one of the interesting analysis on Boeing for my own perusal and anyone who come to this site. If you want to belong on this stock you have to be willing to put aside your capital for 2 to 5 years. BA like the airline industry is a cyclical stock that goes up and down with the economy. The current low of BA is not different than Airbus with both stocks down exactly 59% YTD. This theory of BA has poor management, 737 Max issues, and tons of debt is overblown. Fundamentals have improved over the last week with the management making the right decisions. 1.BA is getting to be a lean company which is the need of the hour. Cutting down the workforce, decrease the inventory rate will help reduce CAPEX and decrease cash burn. While the economy gets better BA can continue to grow revenue through the defense contracts and servicing existing cus

Intro: While doing some research on what stocks to buy, I came up with this stock recommended by Jim Crammer (thru one of the youtube videos posted by CNBC).   "Inovio Pharmaceuticals Inc is a late-stage biotechnology company.  It engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines.  The firm's drug candidates include SynCon immunotherapies which help break the immune system's tolerance of cancerous cells; the CELLECTRA delivery system facilitates optimized cellular uptake of the SynCon immunotherapies." The company was founded by David B. Weiner on June 29, 1983, and is headquartered in Plymouth Meeting, PA. "On April 24, 2020, the company's Chief Executive Joseph Kim said his company's COVID-19 vaccine study backed by the Bill and Melinda Gates Foundation is expected to complete patient enrollment by the end of April.  The study will enroll 40 volunteers who were screened at a medical c

Today's update for Covid-19 from worldometer.info Coronavirus Cases: 2,403,623 view by country Deaths: 165,662 Recovered: 624,693 ACTIVE CASES 1,613,268 Currently Infected Patients 1,559,043  ( 97 %) in Mild Condition 54,225  ( 3 %) Serious or Critical Show Graph Jan 22 Mar 18 Jan 30 Feb 07 Feb 15 Feb 23 Mar 02 Mar 10 Mar 26 Apr 03 Apr 11 0 1M 2M Show Statistics CLOSED CASES 790,355 Cases which had an outcome: 624,693  ( 79 %) Recovered / Discharged 165,662  ( 21 %) Deaths Show Graph Feb 02 Mar 15 Feb 09 Feb 16 Feb 23 Mar 01 Mar 08 Mar 22 Mar 29 Apr 05 Apr 12 0% 100% Show Statistics linear logarithmic Total Coronavirus Cases Total Cases (Linear Scale) Jan 22 Feb 07 Feb 23 Mar 10 Mar 26 Apr 11 0 500k 1,000k 1,500k 2,000k 2,500k Cases linear logarithmic Total Coronavirus Deaths Total Deaths (Linear Scale) Jan 22 Feb 21 Mar 22 Feb 06 Mar 07 Apr 06 0 50k 100k 150k 20